AGLE Overview
Upcoming Projects (AGLE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AGLE)
-
A Second View - Discussing therapies in development for Homocystinuria including Pegtibatinase from Trevere and Pegtarviliase from Aeglea
Tickers: TVTX, AGLE
Executed On: Oct 04, 2022 at 02:00 PM EDT -
Discussing therapies in development for Homocystinuria including Pegtibatinase from Trevere and Pegtarviliase from Aeglea
Tickers: TVTX, AGLE
Executed On: Sep 22, 2022 at 02:00 PM EDT
Expired Projects (AGLE)
-
A Second View: Discussing therapies in development for Homocystinuria including Pegtibatinase from Trevere and Pegtarviliase from Aeglea
Tickers: TVTX, AGLE
Execute By: Sep 30, 2022 -
Discussing therapies in development for Homocystinuria including Pegtibatinase from Trevere and Pegtarviliase from Aeglea - 2nd look
Tickers: AGLE, TVTX
Execute By: Sep 30, 2022 -
Analyzing Aeglea BioTherapeutics’s Pegzilarginase in Patients with Arginase 1 Deficiency, following Phase 3 Data Release
Ticker: AGLE
Execute By: Jan 31, 2022
Upcoming & Overdue Catalysts (AGLE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AGLE)
-
Aeglea Bio's (AGLE) Phase 1/2 20-week repeat dose data of Pegzilarginase (AEB1102) in Arginase I deficiency due at SSIEM Sept 4
Ticker: AGLE
Occurred on: Sep 03, 2019
Strategic Initiatives (AGLE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
